Arthur F. Ryan - 01 Dec 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Issuer symbol
REGN
Transactions as of
01 Dec 2021
Net transactions value
-$63,753
Form type
4
Filing time
02 Dec 2021, 15:07:49 UTC
Previous filing
03 Nov 2021
Next filing
05 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -500 -2.2% $0.000000 22,591 16 Nov 2021 Direct
transaction REGN Common Stock Sale $631 -1 -0% $631.15 22,590 01 Dec 2021 Direct F1
transaction REGN Common Stock Sale $4,428 -7 -0.03% $632.63 22,583 01 Dec 2021 Direct F1, F2
transaction REGN Common Stock Sale $1,267 -2 -0.01% $633.47 22,581 01 Dec 2021 Direct F1, F3
transaction REGN Common Stock Sale $6,980 -11 -0.05% $634.56 22,570 01 Dec 2021 Direct F1, F4
transaction REGN Common Stock Sale $5,718 -9 -0.04% $635.36 22,561 01 Dec 2021 Direct F1, F5
transaction REGN Common Stock Sale $636 -1 -0% $636.50 22,560 01 Dec 2021 Direct F1
transaction REGN Common Stock Sale $14,030 -22 -0.1% $637.75 22,538 01 Dec 2021 Direct F1, F6
transaction REGN Common Stock Sale $7,663 -12 -0.05% $638.62 22,526 01 Dec 2021 Direct F1, F7
transaction REGN Common Stock Sale $15,348 -24 -0.11% $639.49 22,502 01 Dec 2021 Direct F1, F8
transaction REGN Common Stock Sale $3,202 -5 -0.02% $640.47 22,497 01 Dec 2021 Direct F1, F9
transaction REGN Common Stock Sale $3,847 -6 -0.03% $641.23 22,491 01 Dec 2021 Direct F1, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 7 shares of Company stock on December 1, 2021 at prices ranging from $632.00 to $632.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
F3 Represents volume-weighted average price of sales of 2 shares of Company stock on December 1, 2021 at prices ranging from $633.21 to $633.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 11 shares of Company stock on December 1, 2021 at prices ranging from $634.05 to $634.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 9 shares of Company stock on December 1, 2021 at prices ranging from $635.06 to $635.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 22 shares of Company stock on December 1, 2021 at prices ranging from $637.17 to $637.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 12 shares of Company stock on December 1, 2021 at prices ranging from $638.03 to $638.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 24 shares of Company stock on December 1, 2021 at prices ranging from $639.01 to $639.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
F9 Represents volume-weighted average price of sales of 5 shares of Company stock on December 1, 2021 at prices ranging from $640.01 to $640.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.
F10 Represents volume-weighted average price of sales of 6 shares of Company stock on December 1, 2021 at prices ranging from $641.01 to $641.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2021 at each separate price.